TY - JOUR
T1 - Preventive care in prostate cancer patients
T2 - Following diagnosis and for five-year survivors
AU - Snyder, Claire F.
AU - Frick, Kevin D.
AU - Herbert, Robert J.
AU - Blackford, Amanda L.
AU - Neville, Bridget A.
AU - Carducci, Michael A.
AU - Earle, Craig C.
N1 - Funding Information:
Acknowledgement This research was funded through the Ho Ching Yang Memorial Faculty Fellowship Award from the Johns Hopkins Bloomberg School of Public Health. Drs. Snyder and Carducci are also supported by a Mentored Research Scholar Grant from the American Cancer Society (MRSG-08-011-01-CPPB). Dr. Carducci is also supported by a National Cancer Institute Center Grant (5P30CA006973).
PY - 2011/9
Y1 - 2011/9
N2 - Introduction: Prostate cancer is the most common male cancer. Survival rates are high, making preventive care maintenance important. Factors associated with prostate-cancer cases' preventive care in the short-term (Year 1) and long-term (Year 5), and how survivors' care compares to non-cancer controls, require study. Methods: This retrospective, controlled SEER-Medicare study included loco-regional prostate cancer cases age ≥66 in fee-for-service Medicare diagnosed in 2000 and surviving ≥12 months, and non-cancer controls matched to cases on socio-demographics and survival. Outcomes included influenza vaccination, cholesterol screening, and colorectal cancer screening. Independent variables were number of physician visits, physician specialties visited, initial prostate cancer treatment, socio-demographic characteristics, and case-control status. Results: There were 13,507 cases and 13,507 controls in Year 1, and 10,482 cases and 10,482 controls in Year 5. In Years 1 and 5, total number of visits (6/6 outcomes) and primary care provider (PCP) visits (5/6 outcomes) were most consistently associated with preventive care receipt. In Year 1, prostate cancer cases were more likely than controls to receive influenza vaccination (48% vs. 45%) but less likely to receive colorectal cancer screening (29% vs. 31%) (both p < 0. 0001). In Year 5, prostate cancer cases remained more likely than controls to receive influenza vaccination (46% vs. 44%; p < 0. 0001). Conclusions: Differences in survivors' short-term preventive care did not lead to worse long-term preventive care. The number of physician visits, particularly PCP visits, are important factors associated with appropriate care. Implications for Cancer SurvivorsPCP involvement in prostate cancer patients' care is critical both during treatment and for long-term survivors.
AB - Introduction: Prostate cancer is the most common male cancer. Survival rates are high, making preventive care maintenance important. Factors associated with prostate-cancer cases' preventive care in the short-term (Year 1) and long-term (Year 5), and how survivors' care compares to non-cancer controls, require study. Methods: This retrospective, controlled SEER-Medicare study included loco-regional prostate cancer cases age ≥66 in fee-for-service Medicare diagnosed in 2000 and surviving ≥12 months, and non-cancer controls matched to cases on socio-demographics and survival. Outcomes included influenza vaccination, cholesterol screening, and colorectal cancer screening. Independent variables were number of physician visits, physician specialties visited, initial prostate cancer treatment, socio-demographic characteristics, and case-control status. Results: There were 13,507 cases and 13,507 controls in Year 1, and 10,482 cases and 10,482 controls in Year 5. In Years 1 and 5, total number of visits (6/6 outcomes) and primary care provider (PCP) visits (5/6 outcomes) were most consistently associated with preventive care receipt. In Year 1, prostate cancer cases were more likely than controls to receive influenza vaccination (48% vs. 45%) but less likely to receive colorectal cancer screening (29% vs. 31%) (both p < 0. 0001). In Year 5, prostate cancer cases remained more likely than controls to receive influenza vaccination (46% vs. 44%; p < 0. 0001). Conclusions: Differences in survivors' short-term preventive care did not lead to worse long-term preventive care. The number of physician visits, particularly PCP visits, are important factors associated with appropriate care. Implications for Cancer SurvivorsPCP involvement in prostate cancer patients' care is critical both during treatment and for long-term survivors.
KW - Preventive care
KW - Prostate cancer
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=80052028772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052028772&partnerID=8YFLogxK
U2 - 10.1007/s11764-011-0181-y
DO - 10.1007/s11764-011-0181-y
M3 - Article
C2 - 21553320
AN - SCOPUS:80052028772
SN - 1932-2259
VL - 5
SP - 283
EP - 291
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 3
ER -